Tislelizumab Biosimilar - Research Grade

Human

PD-1

1.0 - 5.0 mg/ml

Human IgG4

Humanized

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Functional Assays

Stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.

Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Detects human PD-1. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Tislelizumab.

Blue ice

Programmed death-1 (PD-1) signalling dampens effector T-cell function, making it a key handle for immuno-oncology studies. This antibody is an unconjugated, non-therapeutic analog of tislelizumab directed at human PD-1 and validated for functional assays. It is provided for research use only, formulated with low endotoxin for in vivo suitability, and produced in scalable milligram to gram quantities for bulk and high-throughput laboratories. Typical uses include receptor-blockade controls, T-cell activation assays, in vitro screening, in vivo tumour models, and reference applications during biologics development, with reliable lot-to-lot reproducibility across high-throughput experimental campaigns.

Programmed cell death protein 1, Pdcd1, CD279

Q15116

ICH3002

https://www.imgt.org/mAb-DB/